Before initiating FARXIGA in these patients, assess volume status and renal function. Patients with impaired renal function (eGFR less than 60 mL/min/1.73 m 2), elderly patients, or patients on loop diuretics may be at increased risk for volume depletion or hypotension. Acute kidney injury requiring hospitalization and dialysis has been reported in patients with type 2 diabetes receiving SGLT2 inhibitors, including FARXIGA.
If suspected, discontinue FARXIGA, evaluate and treat promptly. Assess patients who present with signs and symptoms of metabolic acidosis for ketoacidosis, regardless of blood glucose level. In placebo-controlled trials of patients with type 1 diabetes, the risk of ketoacidosis was increased in patients who received SGLT2 inhibitors compared to patients who received placebo. Ketoacidosis in Diabetes Mellitus has been reported in patients with type 1 and type 2 diabetes receiving FARXIGA.Prior serious hypersensitivity reaction to FARXIGA.If you have any questions regarding this offer, please call 1-84.īY USING THIS CARD, YOU AND YOUR PHARMACIST UNDERSTAND AND AGREE TO COMPLY WITH THESE ELIGIBILITY REQUIREMENTS AND TERMS OF USE. Offer must be presented along with a valid prescription at the time of purchase. This offer is not conditioned on any past, present or future purchase, including refills. AstraZeneca reserves the right to rescind, revoke, or amend this offer, eligibility and terms of use at any time without notice. Patients, pharmacists, and prescribers cannot seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this offer. Void where prohibited by law, taxed or restricted. Non-transferable, limited to one per person, cannot be combined with any other offer. Patient is responsible for applicable taxes, if any. If you pay cash for your prescription, AstraZeneca will pay up to the first $150, and you will be responsible for any remaining balance, for each monthly prescription. TERMS OF USE: Eligible commercially insured patients with a valid prescription for FARXIGA ® (dapagliflozin) who present this savings card at participating pharmacies will pay as low as $0 per 30-day supply subject to a maximum savings of $175 per 30-day supply. This offer is not insurance, is restricted to residents of the United States and Puerto Rico, and to patients over 18 years of age. If you are enrolled in a state or federally funded prescription insurance program, you may not use this savings card even if you elect to be processed as an uninsured (cash-paying) patient. This includes patients enrolled in Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD) programs or TriCare, and patients who are Medicare eligible and enrolled in an employer-sponsored group waiver health plan or government-subsidized prescription drug benefit program for retirees. Patients who are enrolled in a state or federally funded prescription insurance program are not eligible for this offer.
#FARXIGA FREE 30 DAY TRIAL FULL#
For Mail Order: Call the number on the card and ask for Customer Service, or click here to download the mail-in rebate form.ĮLIGIBILITY: You may be eligible for this offer if you are insured by commercial insurance and your insurance does not cover the full cost of your prescription, or you are not insured and are responsible for the cost of your prescriptions.
0 kommentar(er)
